Atypical 111In-diaethylenotriamino pentaacetic acid-octreotide and 99mTc-(V)-dimercapto succini acid uptake patterns, after radiation treatment

Hellenic Journal of Nuclear Medicine

Volumn 11, Issue 2, 2008, Pages 127-129

  Bozkurt, M Fani ^a   Ergun, Eser Lay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PENTETATE INDIUM IN 111; SUCCIMER TC 99M; 111IN OCTREOTIDE, DTPA(0); 111IN-OCTREOTIDE, DTPA(0)-; DIAGNOSTIC AGENT; DRUG DERIVATIVE; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT;

ADULT; BACKACHE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG TRANSPORT; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMAGE ANALYSIS; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; PRIMARY TUMOR; RADIATION INJURY; RADIATION RESPONSE; RECURRENT CANCER; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYMOMA; TUMOR LOCALIZATION; WHOLE BODY SCINTISCANNING; LUNG TUMOR; METABOLISM; MIDDLE AGED; SCINTISCANNING;

ADULT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 51549111365     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Behr TM, Gratz S, Markus PM et al. Enhanced bilateral somatostatin receptor expression in mediastinal lymph nodes («chimney sign») in occult metastatic medullary thyroid cancer: a typical site of tumour manifestation? Eur J Nucl Med 1997; 24: 184-191.
2. 99mTc-DMSA scintigraphy in small cell and nonsmall cell lung cancers. Nuklearmedizin 1997; 36: 223-227.
3. 99mTc-V-DMSA. J Nucl Med 1995; 36: 202-207.
4. Ergun EL, Ugur O. Metabolic and receptor imaging in gastroenteropancreatic neuroendocrine tumors. In: Yalcin S ed. Neuroendocrine Tumors of Gastroenteropancreatic System. 1st edn. Form Reklam Hizmetleri, Ankara, 2006; 101-116.
5. 111In-pentetreotide by pleural plaques. Clin Nucl Med 1998; 23:298-301.
6. Elliott DE, Li J, Blum AM et al. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. European J Immunology 1999; 29: 2454-2463.
7. 99mTc-V-DMSA scintigraphy. J Postgrad Med 1995; 41: 12-13.
8. Jong M, Sundram FX. Two cases of medullary thyroid carcinoma. Ann Acad Med Singapore 2001; 30: 646-650.
9. 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 1996; 23: 1367-1371.
10. Ohta H, Endo K, Konishi J et al. Scintigraphic evaluation of aggressive fibromatosis. J Nucl Med 990; 31: 1632-1634.
11. 99mTc-(V)-dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging. J Nucl Med 1989; 30: 174-180.
12. 99mTc-MIBI. Eur J Nucl Med 2001; 28: 923-928.
13. 99mTc-dimercaptosuccinic acid imaging of hepatocellular carcinoma. Neoplasma 1999; 46: 246-248.
14. 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma. Hell J Nucl Med 2005; 8:162-164.
15. 99mTc-(V)-DMSA scintimammography. Am J Clin Oncol 2007: 30: 420-427.